Sugi Predict

Sugi Predict / Compounds / SCHEMBL712420

SCHEMBL712420

SCHEMBL712420

CC(C)Oc1cc(OCc2ccccc2)ccc1-c1nc2cc(-c3ccccc3C(F)(F)F)cnc2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCD O00767 1/20 0.42
▸ TRPA1 O75762 1/20 0.42
▸ FFAR1 O14842 1/20 0.36
▸ NR1H4 Q96RI1 2/20 0.35
▸ PPARG P37231 1/20 0.35
▸ PPARA Q07869 1/20 0.35
▸ PDK2 Q15119 1/20 0.35
▸ MAPT P10636 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ MCL1 Q07820 1/20 0.34
▸ PTGES O14684 3/20 0.34
▸ MAPK1 P28482 2/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.34
▸ PDGFRB P09619 1/20 0.34
▸ PDGFRA P16234 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ MRGPRX4 Q96LA9 1/20 0.34
▸ USP1 O94782 1/20 0.34
▸ WDR48 Q8TAF3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL711145 0.93 SCD (0.42) SCDTRPA1FFAR1NR1H4PPARG
SCHEMBL709187 0.89 MAPT (0.36) FFAR1MAPTKDM4EMCL1MAPK1
SCHEMBL10206529 0.89 MAPT (0.41) MAPTKDM4EMCL1MAPK1NPSR1
SCHEMBL713547 0.88 PRMT5 (0.39) FFAR1NR1H4MAPTKDM4EMCL1
SCHEMBL711250 0.88 GPR34 (0.41) —
SCHEMBL720491 0.87 MAPT (0.46) FFAR1MAPTKDM4EMAPK1NPSR1
SCHEMBL710530 0.87 MAPT (0.42) MAPTKDM4EMCL1MAPK1NPSR1
SCHEMBL713315 0.87 PRMT5 (0.38) FFAR1NR1H4MAPTKDM4EMCL1
Trifluoroacetic Acid SCHEMBL710810 0.87 MCL1 (0.41) SCDPPARAMAPTKDM4EMCL1
SCHEMBL710858 0.86 SCD (0.43) SCDTRPA1FFAR1NR1H4PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940837-B1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL (JP) 2012-11-07 — — EP disclosed
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 — — US disclosed
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 — — US disclosed
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 — — US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 — — US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 — — US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 — — US disclosed
EP-1940837-A2 IMIDAZOPYRIDINE COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2008-07-09 — — EP disclosed
WO-2007028135-A2 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS GCK, GCKR, KHK SCD 2937/4885TRPA1 3722/4885FFAR1 3394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.